BRCA1 and breast cancer: There has been a resurgence of interest in cisplatin in TNBC, in part due to improvements in its side-effect management strategies and additional preclinical data suggesting that platinum may be particularly active in TNBC, as there are histological similarities between BRCA1-mutated BC and TNBC [16].